Leishmania is a protozoan parasite that resides in mammalian macrophages and inflicts the disease known as
leishmaniasis. Although prevalent in 88 countries, an anti-leishmanial
vaccine remains elusive. While comparing the virulent and avirulent L. major transcriptomes by microarray, PCR and functional analyses for identifying a novel virulence-associated gene, we identified LmjF.36.3850, a hypothetical
protein significantly less expressed in the avirulent parasite and without any known function. Motif search revealed that LmjF.36.3850
protein shared phosphorylation sites and other structural features with
sucrose non-fermenting
protein (Snf7) that shuttles
virulence factors. LmjF.36.3850 was predicted to bind
diacylglycerol (DAG) with energy value similar to PKCα and PKCβ, to which DAG is a cofactor. Indeed,
1-oleoyl-2-acetyl-sn-glycerol (OAG), a DAG analogue, enhanced the phosphorylation of PKCα and PKCβI. We cloned LmjF.36.3850 gene in a mammalian expression vector and primed susceptible BALB/c mice followed by challenge
infection. We observed a higher parasite load, comparable antibody response and higher anti-inflammatory
cytokines such as
IL-4 and
IL-10, while expression of major anti-leishmanial
cytokine, IFN-γ, remained unchanged in LmjF.36.3850-vaccinated mice. CSA restimulated LN cells from vaccinated mice after challenge
infection secreted comparable
IL-4 and
IL-10 but reduced IFN-γ, as compared to controls. These observations suggest a skewed Th2 response, diminished IFN-γ secreting Th1-TEM cells and increased central and effector memory subtype of Th2, Th17 and Treg cells in the vaccinated mice. These data indicate that LmjF.36.3850 is a plausible
virulence factor that enhances disease-promoting response, possibly by interfering with PKC activation and by eliciting disease-promoting T cells.